NCT05290493 - NB-001 in Children and Adolescents With 22q11 Deletion Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

June 1, 2023

Study Completion Date

June 9, 2023

Conditions

22q11 Deletion Syndrome

Interventions

DRUG

NB-001

Non-stimulant modulator of metabotropic glutamate receptors (mGluRs)

OTHER

Placebo

Matching, inactive placebo

Trial Locations (4)

Children's Hospital of Philadelphia (CHOP), Philadelphia

Children's Hospital Colorado, Aurora

Seattle Children's Hospital, Seattle

The Hospital for Sick Children (SickKids), Toronto